en

PRODUCT DETAIL

Ledraxen 4 000 IU (40 mg)/0,4 ml injekčný roztok v naplnenej injekčnej striekačke

Code 2782E
MA number 16/0021/23-S
Product Form: sol iru 10x4 000 IU (40 mg)/0,4 ml (striek.inj.napl.skl. bez bezp. systému)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
MAH, country: Venipharm, France
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AB Heparin group
B01AB05 Enoxaparin
Shelf life: 36
Route of admin.: Extracorporeal, intravenous and subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 15.02.2023
SPC: SPC_Ledraxen_injekčný roztok v naplnenej injekčnej striekačke_08.2023.pdf  
PIL: PIL_Ledraxen_injekčný roztok v naplnenej injekčnej striekačke_08.2023.pdf  
Safety feature Yes
Data update: 03.11.2023
eu-flag.png sk-flag.png